At ASTRO 2026, DJohn Hillson details how early post-surgical radiation education within 6 weeks improves outcomes for head and neck cancer patients.
|Articles|June 24, 2015
Jeannie Woith Discusses the Benefits of Low-Level Laser Therapy for Oral Mucositis
Author(s)Jeannie Woith, BSN, RN, LMT
Jeannie Woith, BSN, RN, LMT, The James Cancer Hospital, The Ohio State University, discusses the benefits of treating oral mucositis with low-level laser therapy.
Advertisement
Jeannie Woith, BSN, RN, LMT, The James Cancer Hospital, The Ohio State University, discusses the benefits of treating oral mucositis with low-level laser therapy.
Advertisement
Related to this article
At ASTRO 2026, Suresh Rana details how AI-driven contouring accelerates care timelines, requiring rigorous team monitoring and early nursing input.
At ASTRO 2026, Dr. Erica Braschi Jordan details toxicity tracking, physical therapy referral, and quality of life in proton regional nodal irradiation.
At ASTRO 2026, Dr. Mishaal Munir details how nurse-led triage workflows and prompt symptom escalations improve care for breast cancer brain metastases.
ASTRO 2026 presenter Kayla Kafka-Peterson details an Adapt-Adopt-Build model to bridge global brachytherapy nursing gaps and standardize perioperative care.
At ASTRO 2026, Dr. Nitin Ohri details additive versus synergistic toxicities when combining radiation with novel systemic therapies in clinical trials.
APHON 2026 speaker Amy C. Haskamp, CNS, discusses tiered self-care tactics and boundaries to help pediatric oncology nurses navigate emotional distress and burnout.
Jyoti Malhotra, MD, MPH, joins The Moonlight Shift to discuss first-in-human phase 1 lung cancer trials, healthcare access, and her work at Yale Cancer Center.
Advertisement
Advertisement
Trending on Oncology Nursing News
1
The Importance of Precise Clinical Communication in Oncology Nursing
2
FDA Approves Pirtobrutinib for Untreated CLL/SLL
3
Balancing Treatment Efficacy and Quality of Life in Metastatic Triple-Negative Breast Cancer
4
Administering Intravesical Therapies and Dosing Schedules
5